NSDL has received SEBI’s in-principle approval for a stock exchange listing by August 14, following delays due to valuation negotiations. The IPO, initially planned for July, is now expected to launch by late July or early August, targeting a ₹16,000 crore valuation. The issue size has been reduced to 50.
Molbio Diagnostics shares rally 9% as Jefferies initiates ‘high conviction top pick’ call for recently listed stock. Why is it bullish?
Molbio Diagnostics shares jumped after Jefferies initiated coverage with a Buy rating and named it a high-conviction top pick. The brokerage set a Rs 1,600